Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

181 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Early progression of disease as a predictor of survival in chronic lymphocytic leukemia.
Ahn IE, Farber CM, Davids MS, Grinblatt DL, Kay NE, Lamanna N, Mato A, Nabhan C, Kiselev P, Swern AS, Flick ED, Sullivan K, Sharman JP, Flowers CR. Ahn IE, et al. Among authors: davids ms. Blood Adv. 2017 Nov 28;1(25):2433-2443. doi: 10.1182/bloodadvances.2017011262. eCollection 2017 Nov 28. Blood Adv. 2017. PMID: 29296893 Free PMC article.
Idelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicity.
Lampson BL, Kasar SN, Matos TR, Morgan EA, Rassenti L, Davids MS, Fisher DC, Freedman AS, Jacobson CA, Armand P, Abramson JS, Arnason JE, Kipps TJ, Fein J, Fernandes S, Hanna J, Ritz J, Kim HT, Brown JR. Lampson BL, et al. Among authors: davids ms. Blood. 2016 Jul 14;128(2):195-203. doi: 10.1182/blood-2016-03-707133. Epub 2016 May 31. Blood. 2016. PMID: 27247136 Free PMC article. Clinical Trial.
Phase 1 trial of rituximab, lenalidomide, and ibrutinib in previously untreated follicular lymphoma: Alliance A051103.
Ujjani CS, Jung SH, Pitcher B, Martin P, Park SI, Blum KA, Smith SM, Czuczman M, Davids MS, Levine E, Lewis LD, Smith SE, Bartlett NL, Leonard JP, Cheson BD. Ujjani CS, et al. Among authors: davids ms. Blood. 2016 Nov 24;128(21):2510-2516. doi: 10.1182/blood-2016-06-718106. Epub 2016 Oct 3. Blood. 2016. PMID: 27697771 Free PMC article. Clinical Trial.
Characterizing and prognosticating chronic lymphocytic leukemia in the elderly: prospective evaluation on 455 patients treated in the United States.
Nabhan C, Mato A, Flowers CR, Grinblatt DL, Lamanna N, Weiss MA, Davids MS, Swern AS, Bhushan S, Sullivan K, Flick ED, Kiselev P, Sharman JP. Nabhan C, et al. Among authors: davids ms. BMC Cancer. 2017 Mar 16;17(1):198. doi: 10.1186/s12885-017-3176-x. BMC Cancer. 2017. PMID: 28302090 Free PMC article. Clinical Trial.
Targeting BCL-2 in B-cell lymphomas.
Davids MS. Davids MS. Blood. 2017 Aug 31;130(9):1081-1088. doi: 10.1182/blood-2017-04-737338. Epub 2017 Jul 19. Blood. 2017. PMID: 28724540 Free article. Review.
Safety profiles of novel agent therapies in CLL.
Ahn IE, Davids MS. Ahn IE, et al. Among authors: davids ms. Hematology Am Soc Hematol Educ Program. 2017 Dec 8;2017(1):354-357. doi: 10.1182/asheducation-2017.1.354. Hematology Am Soc Hematol Educ Program. 2017. PMID: 29222278 Free PMC article. Review.
181 results